Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Related Citations for PubMed (Select 24560676)

1.

Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women.

Ko SC, Schillie SF, Walker T, Veselsky SL, Nelson NP, Lazaroff J, Crowley S, Dusek C, Loggins K, Onye K, Fenlon N, Murphy TV.

Vaccine. 2014 Apr 11;32(18):2127-33. doi: 10.1016/j.vaccine.2014.01.099. Epub 2014 Feb 22.

PMID:
24560676
2.

Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Sep 28;61:768-71.

4.

Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers.

Zou H, Chen Y, Duan Z, Zhang H.

PLoS One. 2011;6(10):e26748. doi: 10.1371/journal.pone.0026748. Epub 2011 Oct 28.

5.

Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.

Losonsky GA, Wasserman SS, Stephens I, Mahoney F, Armstrong P, Gumpper K, Dulkerian S, West DJ, Gewolb IH.

Pediatrics. 1999 Feb;103(2):E14.

PMID:
9925860
6.

[Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].

Wang J, Feng YL, Liu MH, Bai Y, Feng DH, Yuan NX, Du DQ, Feng WH, Liu HL, Yang Y, Liu JF, He YL, Song HX, Liu Y, Zhao YR, Chen TY.

Zhonghua Gan Zang Bing Za Zhi. 2013 Aug;21(8):580-3. doi: 10.3760/cma.j.issn.1007-3418.2013.08.005. Chinese.

PMID:
24119736
7.

Post-vaccination serological test results of infants at risk of perinatal transmission of hepatitis B using an intensified follow-up programme in a London centre.

Tong CY, Robson C, Wu Y, Issa R, Watts T, Wilkinson M, Wong T, Lorek A.

Vaccine. 2013 Jun 28;31(31):3174-8. doi: 10.1016/j.vaccine.2013.04.083. Epub 2013 May 16.

PMID:
23684828
8.

[Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].

Yin YZ, Zhou J, Zhang PZ, Hou HY.

Zhonghua Gan Zang Bing Za Zhi. 2013 Feb;21(2):105-10. doi: 10.3760/cma.j.issn.1007-3418.2013.02.008. Chinese.

PMID:
23663881
9.

Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?

Chen T, Wang J, Feng Y, Yan Z, Zhang T, Liu M, Bai Y, Song H, Liu H, Yang Y, Liu J, He Y, Chen Y, Zhang S, Zhuang G, Liang X, Liu Z, Xu X, Chen W, Liu Y, Zhao Y.

BMC Infect Dis. 2013 Nov 6;13:524. doi: 10.1186/1471-2334-13-524.

10.

Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women.

Euler GL, Copeland JR, Rangel MC, Williams WW.

Pediatr Infect Dis J. 2003 Feb;22(2):123-9.

PMID:
12586975
11.

Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.

Biroscak BJ, Fiore AE, Fasano N, Fineis P, Collins MP, Stoltman G.

Pediatrics. 2003 Jun;111(6 Pt 1):e645-9.

PMID:
12777580
12.

The effects of booster vaccination on hepatitis B vaccine in anti-HBs negative infants of HBsAg-positive mothers after primary vaccination.

Gu H, Yao J, Zhu W, Lv H, Cheng S, Ling L, Xia S, Chen Y.

Hum Vaccin Immunother. 2013 Jun;9(6):1292-5. doi: 10.4161/hv.24021. Epub 2013 Feb 19.

13.

Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.

Yang YJ, Liu CC, Chen TJ, Lee MF, Chen SH, Shih HH, Chang MH.

Pediatr Infect Dis J. 2003 Jul;22(7):584-8.

PMID:
12867831
14.

Prevention of perinatal hepatitis B virus transmission in the Netherlands, 2003-2007: children of Chinese mothers are at increased risk of breakthrough infection.

Hahné S, van den Hoek A, Baayen D, van der Sande M, de Melker H, Boot H.

Vaccine. 2012 Feb 21;30(9):1715-20. doi: 10.1016/j.vaccine.2011.12.071. Epub 2011 Dec 30.

PMID:
22210140
15.

A program for eradication of hepatitis B from Taiwan by a 10-year, four-dose vaccination program.

Chen DS, Hsu HM, Bennett CL, Pajeau TS, Blumberg B, Chang PY, Nishioka K, Huang A, Sung JL.

Cancer Causes Control. 1996 May;7(3):305-11.

PMID:
8734823
16.

Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review.

Schillie SF, Murphy TV.

Vaccine. 2013 May 17;31(21):2506-16. doi: 10.1016/j.vaccine.2012.12.012. Epub 2012 Dec 17. Review.

PMID:
23257713
17.

[A follow-up study on the efficacy of hepatitis B immunoglobulin combining hepatitis B vaccine in infants born to HBsAg positive mothers].

Wang Y, Yan YP, Zhang Y, Men K, Su HX, Li D, Xu DZ, Zhang HQ, Li J.

Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Jun;28(6):550-4. Chinese.

PMID:
17939382
18.

Chronic HBV infection among pregnant women and their infants in Shenyang, China.

Ding Y, Sheng Q, Ma L, Dou X.

Virol J. 2013 Jan 7;10:17. doi: 10.1186/1743-422X-10-17.

19.

Screening of pregnant women for hepatitis B virus surface antigen (HBsAg) and subsequent management, Qiandongnan prefecture, Guizhou, China, 2010.

Huang Y, Li L, Sun X, Lu M, Liu H, Tang G, Wang D, Hutin YJ.

Vaccine. 2013 Dec 27;31 Suppl 9:J62-5. doi: 10.1016/j.vaccine.2013.05.103.

PMID:
24331022
20.

Prevention of perinatal transmission of the hepatitis B virus. Outcome of infants in a community prevention program.

Niu MT, Targonski PV, Stoll BJ, Albert GP, Margolis HS.

Am J Dis Child. 1992 Jul;146(7):793-6.

PMID:
1496944
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk